Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct

Cancer

Volumn 82, Issue 1, 1998, Pages 86-95

  Suto, Takayuki ^a   Sugai, Tamotsu ^a   Nakamura, Shin Ichi ^a   Funato, Osamu ^a   Nitta, Hiroyuki ^a   Sasaki, Ryoko ^a   Kanno, Senji ^a   Saito, Kazuyoshi ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Argyrophilic nucleolar organizer region; Carcinoma of the extrahepatic bile duct; Immunohistochemistry; Ki 67 antigen; MIB 1; p53

Indexed keywords

MONOCLONAL ANTIBODY KI 67; NUCLEAR PROTEIN; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BILE DUCT CARCINOMA; CANCER SURVIVAL; CHROMOSOME NOR; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CARCINOMA; COLORING AGENTS; FEMALE; FIXATIVES; FORECASTING; FORMALDEHYDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEOLUS ORGANIZER REGION; PARAFFIN EMBEDDING; PROGNOSIS; RETROSPECTIVE STUDIES; SILVER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031943659     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980101)82:1<86::AID-CNCR10>3.0.CO;2-9     Document Type: Article

References (41)

1. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20.
2. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5.
3. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
4. Diebold J, Dopfer K, Lai M, Lohrs U. Comparison of different monoclonal antibodies for the immunohistochemical assessment of cell proliferation in routine colorectal biopsy specimens. Scand J Gastroenterol 1994;29:47-53.
5. Remmele W, Muhlfait V, Keul HG. Estimation of the proliferative activity of human breast cancer tissue by means of the Ki-67 and MIB-1 antibodies - comparative studies on frozen and paraffin sections. Virchows Arch 1995;426:435-9.
6. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991;351:453-6.
7. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 1986;18:5-14.
8. Ploton D, Bobichon H, Adnet J-J. Ultrastructural localization of NOR in nucleoli of human breast cancer tissues using a one-step Ag-NOR staining method. Biol Cell 1982;43:229-32
9. Derenzini M, Sirri V, Trere D, Ochs RL. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab Invest 1995; 73:497-502.
10. Japanese Society of Biliary Surgery. General rules for surgical and pathological studies on cancer of biliary tract. 3rd edition. Tokyo: Kanehara & Co., Ltd., 1993.
11. Hernmanek P, Sobin LH, editors. UICC TNM classification of malignant tumours. 4th edition. Berlin: Springer-Verlag, 1987:56-67.
12. Vojtesek B, Bártek J, Midgley CA, Lane DP. An immunochemical analysis of the human nuclear phosphoprotein p53 new monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992;151:237-44.
13. Schoenthaler R, Phillips TL, Castro J, Efird JT, Better A, Way LW. Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience. Ann Surg 1994;219:267-74.
14. Bhuiya MR, Nimura Y, Kamiya J, Kondo S, Nagino M, Hayakawa N. Clinicopathologic factors influencing survival of patients with bile duct carcinoma: multivariate statistical analysis. World J Surg 1993;17:653-7.
15. Lam K-Y, Law SY-K, So MK-P, Fok M, Ma LT, Wong J. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma. Cancer 1996;77:7-13.
16. Pich A, Margaria E, Chiusa L. Proliferative activity is a significant prognostic factor in male breast carcinoma. Am J Pathol 1994;145:481-9.
17. Washington K, Gottfried MR. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. Liver 1996;16:99-104.
18. Teh M, Wee A, Raju GC. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile ducts ampullary carcinomas. Cancer 1994;74:1542-5.
19. Lee YC, Song SY, Chung JB, Kang JK, Park IS. p53 protein expression in extrahepatic bile duct cancer. Yonsei Med J 1996;37:112-7.
20. Diamantis I, Karamitopoulou E, Perentes E, Zimmermann A. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Hepatology 1995;22:774-9.
21. Suto T, Sasaki K, Sugai T, Kanno S, Saito K. Heterogeneity in the nuclear DNA content of cells in carcinomas of the biliary tract and pancreas. Cancer 1993;72:2920-8.
22. Cameron JL, Pitt HA, Zinner MJ, Kaufman SL, Coleman J. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg 1990;159:91-7.
23. Oberfield RA, Rossi RL. The role of chemotherapy in the treatment of bile duct cancer. World J Surg 1988;12:105-8.
24. Oka K, Nakano T, Hoshi T. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices. Cancer 1996;77:2280-5.
25. Youssef EM, Matsuda T, Takada N, Osugi H, Higashino M, Kinoshita H, et al. Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer 1995;76:358-66.
26. Kakeji Y, Korenaga D, Tsujitani S, Haraguchi M, Maehara Y, Sugimachi K. Predictive value of Ki-67 and argyrophilic nucleolar organizer region staining for lymph node metastasis in gastric cancer. Cancer Res 1991;51:3503-6.
27. Wintzer HO, Zipfel I, Schulte MJ, Hellerich U, von KS. Ki-67 immunostaining in human breast tumors and its relationship to prognosis. Cancer 1991;67:421-8.
28. Morita M, Kuwano H, Matsuda H, Moriguchi S, Sugimachi K. Prognostic significance of argyrophilic nucleolar organizer regions in esophageal carcinoma. Cancer Res 1991;51:5339-41.
29. Kakeji Y, Maehara Y, Orita H, Emi Y, Ichiyoshi Y, Korenaga D, et al. Argyrophilic nucleolar organizer region in endoscopically obtained biopsy tissue: a useful predictor of nodal metastasis and prognosis in carcinoma of the stomach. J Am Coll Surg 1996;182:482-7.
30. Suzuki T, Takano Y. Comparative immunohistochemical studies of p53 and proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions in pancreatic duct cell carcinomas. Jpn J Cancer Res 1993;84:1072-7.
31. Porschen R, Kriegel A, Langen C, Classen S, Hilse M, Lohe B, et al. Assessment of proliferative activity in carcinomas of the human alimentary tract by Ki-67 immunostaining. Int J Cancer 1991;47:686-91.
32. Pinder SE, Wencyk P, Sibbering DM, Bell JA, Elston CW, Nicholson R, et al. Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. Br J Cancer 1995;71:146-9.
33. Yamaguchi A, Tsukioka Y, Kurosaka Y, Nishimura G, Kanno M, Yonemura Y, et al. Prognostic value of nucleolar organizer regions in endoscopically biopsied tissues of colorectal cancers. Oncology 1993;50:121-6.
34. Raymond WA, Leong AS. Nucleolar organizer regions relate to growth fractions in human breast carcinoma. Hum Pathol 1989;20:741-6.
35. Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kuhn R, Wittekind CW. Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Cancer 1996;77:164-71.
36. Victorzon M, Roberts PJ, Haglund C, von Boguslawsky K, Nordling S. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma. Oncology 1996;53:182-91.
37. Adachi Y, Kido A, Mori M, Matsushima T, Shimono R, Inoue T, et al. Nuclear DNA content and nucleolar organizer regions in colorectal cancer. J Surg Oncol 1995;59:177-80.
38. Hall PA, Crocker J, Watts A, Stansfeld AG. A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma. Histopathology 1988; 12:373-81.
39. Soomro IN, Whimster WF. Growth fraction in lung tumours determined by Ki67 immunostaining and comparison with AgNOR scores. J Pathol 1990;162:217-22.
40. Leonardi E, Girlando S, Serio G, Mauri FA, Perrone G, Scampini S, et al. PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. J Clin Pathol 1992;45:416-9.
41. Lanza GJ, Maestri I, Dubini A, Gafa R, Santini A, Ferretti S, et al. p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival. Am J Clin Pathol 1996;105:604-12.